Published in Hum Brain Mapp on January 01, 2009
Toward discovery science of human brain function. Proc Natl Acad Sci U S A (2010) 15.22
Emerging concepts for the dynamical organization of resting-state activity in the brain. Nat Rev Neurosci (2011) 5.02
Reliable intrinsic connectivity networks: test-retest evaluation using ICA and dual regression approach. Neuroimage (2009) 4.47
Functional alterations in memory networks in early Alzheimer's disease. Neuromolecular Med (2010) 2.77
A resting state network in the motor control circuit of the basal ganglia. BMC Neurosci (2009) 1.97
Brain imaging in Alzheimer disease. Cold Spring Harb Perspect Med (2012) 1.37
Functional connectivity fMRI of the rodent brain: comparison of functional connectivity networks in rat and mouse. PLoS One (2011) 1.28
The default mode network in healthy aging and Alzheimer's disease. Int J Alzheimers Dis (2011) 1.27
Modulation of large-scale brain networks by transcranial direct current stimulation evidenced by resting-state functional MRI. Brain Stimul (2011) 1.25
Disrupted functional brain connectivity in partial epilepsy: a resting-state fMRI study. PLoS One (2012) 1.19
Group-ICA Model Order Highlights Patterns of Functional Brain Connectivity. Front Syst Neurosci (2011) 1.08
Advances in neuroimaging of traumatic brain injury and posttraumatic stress disorder. J Rehabil Res Dev (2009) 1.08
Emergence of persistent networks in long-term intracranial EEG recordings. J Neurosci (2011) 1.07
Resting state activity in patients with disorders of consciousness. Funct Neurol (2011) 1.00
Potential of functional MRI as a biomarker in early Alzheimer's disease. Neurobiol Aging (2011) 0.99
Applications of multivariate pattern classification analyses in developmental neuroimaging of healthy and clinical populations. Front Hum Neurosci (2009) 0.97
The baseline and longitudinal changes of PCC connectivity in mild cognitive impairment: a combined structure and resting-state fMRI study. PLoS One (2012) 0.91
Reduced task-related suppression during semantic repetition priming in schizophrenia. Psychiatry Res (2010) 0.88
Probabilistic sequence learning in mild cognitive impairment. Front Hum Neurosci (2013) 0.88
Model-free functional connectivity and impulsivity correlates of alcohol dependence: a resting-state study. Addict Biol (2015) 0.87
Neural correlates of saccadic inhibition in healthy elderly and patients with amnestic mild cognitive impairment. Front Psychol (2013) 0.85
Aberrant functional organization within and between resting-state networks in AD. PLoS One (2013) 0.85
Multivoxel pattern analysis for FMRI data: a review. Comput Math Methods Med (2012) 0.82
Dynamical stability of intrinsic connectivity networks. Neuroimage (2011) 0.82
Whole-brain functional connectivity during emotional word classification in medication-free Major Depressive Disorder: Abnormal salience circuitry and relations to positive emotionality. Neuroimage Clin (2013) 0.81
Attributed graph distance measure for automatic detection of attention deficit hyperactive disordered subjects. Front Neural Circuits (2014) 0.81
Donepezil impairs memory in healthy older subjects: behavioural, EEG and simultaneous EEG/fMRI biomarkers. PLoS One (2011) 0.80
Early grey matter changes in structural covariance networks in Huntington's disease. Neuroimage Clin (2016) 0.76
Reduced resting-state brain activity in the default mode network in children with (central) auditory processing disorders. Behav Brain Funct (2014) 0.76
Neural correlates of attention-executive dysfunction in lewy body dementia and Alzheimer's disease. Hum Brain Mapp (2015) 0.75
Time-resolved detection of stimulus/task-related networks, via clustering of transient intersubject synchronization. Hum Brain Mapp (2015) 0.75
Neural substrates of motor and cognitive dysfunctions in SCA2 patients: A network based statistics analysis. Neuroimage Clin (2017) 0.75
Association between resting-state brain functional connectivity and muscle sympathetic burst incidence. J Neurophysiol (2015) 0.75
Correlation between resting state fMRI total neuronal activity and PET metabolism in healthy controls and patients with disorders of consciousness. Brain Behav (2015) 0.75
Age-related increase in brain activity during task-related and -negative networks and numerical inductive reasoning. Int J Clin Exp Pathol (2014) 0.75
Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage (2004) 49.54
The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement (2011) 24.26
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol (2007) 18.62
Correspondence of the brain's functional architecture during activation and rest. Proc Natl Acad Sci U S A (2009) 16.93
Investigations into resting-state connectivity using independent component analysis. Philos Trans R Soc Lond B Biol Sci (2005) 16.87
FSL. Neuroimage (2011) 15.56
Toward discovery science of human brain function. Proc Natl Acad Sci U S A (2010) 15.22
Probabilistic independent component analysis for functional magnetic resonance imaging. IEEE Trans Med Imaging (2004) 14.60
Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. N Engl J Med (2010) 13.82
Mild cognitive impairment. Lancet (2006) 10.21
Distinct patterns of brain activity in young carriers of the APOE-epsilon4 allele. Proc Natl Acad Sci U S A (2009) 9.19
Bayesian analysis of neuroimaging data in FSL. Neuroimage (2008) 9.10
Revising the definition of Alzheimer's disease: a new lexicon. Lancet Neurol (2010) 8.74
General multilevel linear modeling for group analysis in FMRI. Neuroimage (2003) 7.79
CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. JAMA (2009) 7.29
Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol (2006) 6.97
Multilevel linear modelling for FMRI group analysis using Bayesian inference. Neuroimage (2004) 6.87
Network modelling methods for FMRI. Neuroimage (2010) 6.61
A Bayesian model of shape and appearance for subcortical brain segmentation. Neuroimage (2011) 6.60
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol (2013) 6.18
Multiplexed echo planar imaging for sub-second whole brain FMRI and fast diffusion imaging. PLoS One (2010) 5.74
The WU-Minn Human Connectome Project: an overview. Neuroimage (2013) 5.49
Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy. N Engl J Med (2006) 5.20
Further Implications of Off-Label Use of Acetazolamide in the Management of Moyamoya Disease in Japan: Response. Radiology (2017) 4.99
The clinical use of structural MRI in Alzheimer disease. Nat Rev Neurol (2010) 4.59
Temporally-independent functional modes of spontaneous brain activity. Proc Natl Acad Sci U S A (2012) 4.44
Altered resting state networks in mild cognitive impairment and mild Alzheimer's disease: an fMRI study. Hum Brain Mapp (2005) 4.11
PML in a patient treated with dimethyl fumarate from a compounding pharmacy. N Engl J Med (2013) 4.02
Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. Hum Mol Genet (2008) 3.93
Advances and pitfalls in the analysis and interpretation of resting-state FMRI data. Front Syst Neurosci (2010) 3.84
Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial. Lancet (2011) 3.76
Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study. Lancet Neurol (2009) 3.65
MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study. Lancet Neurol (2007) 3.47
Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial. Lancet Neurol (2009) 3.42
Distinct cerebellar contributions to intrinsic connectivity networks. J Neurosci (2009) 3.27
Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study. Lancet Neurol (2007) 3.22
Comparison of fingolimod with interferon beta-1a in relapsing-remitting multiple sclerosis: a randomised extension of the TRANSFORMS study. Lancet Neurol (2011) 3.16
Extravascular lung water in sepsis-associated acute respiratory distress syndrome: indexing with predicted body weight improves correlation with severity of illness and survival. Crit Care Med (2008) 3.13
Behavioral interpretations of intrinsic connectivity networks. J Cogn Neurosci (2011) 3.09
Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer's Association Research Roundtable Workgroup. Alzheimers Dement (2011) 3.05
Functional-anatomical validation and individual variation of diffusion tractography-based segmentation of the human thalamus. Cereb Cortex (2004) 3.03
Distinct and overlapping functional zones in the cerebellum defined by resting state functional connectivity. Cereb Cortex (2009) 2.79
Resting-state fMRI in the Human Connectome Project. Neuroimage (2013) 2.78
Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab. Arch Neurol (2011) 2.75
Investigating the electrophysiological basis of resting state networks using magnetoencephalography. Proc Natl Acad Sci U S A (2011) 2.69
Pushing spatial and temporal resolution for functional and diffusion MRI in the Human Connectome Project. Neuroimage (2013) 2.68
Fractionating the default mode network: distinct contributions of the ventral and dorsal posterior cingulate cortex to cognitive control. J Neurosci (2011) 2.65
Chronic cerebrospinal venous insufficiency and multiple sclerosis. Ann Neurol (2010) 2.63
Imaging how attention modulates pain in humans using functional MRI. Brain (2002) 2.60
Small vessel disease and general cognitive function in nondisabled elderly: the LADIS study. Stroke (2005) 2.59
Distinct portions of anterior cingulate cortex and medial prefrontal cortex are activated by reward processing in separable phases of decision-making cognition. Biol Psychiatry (2004) 2.58
Correlation between motor improvements and altered fMRI activity after rehabilitative therapy. Brain (2002) 2.57
Progression of white matter hyperintensities and incidence of new lacunes over a 3-year period: the Leukoaraiosis and Disability study. Stroke (2008) 2.57
Cognitive impairment in heart failure: a systematic review of the literature. Eur J Heart Fail (2006) 2.56
Meta-analysis of neuroimaging data: a comparison of image-based and coordinate-based pooling of studies. Neuroimage (2008) 2.54
Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging. Radiology (2005) 2.47
Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations. J Neurol Neurosurg Psychiatry (2010) 2.44
MRI and the diagnosis of multiple sclerosis: expanding the concept of "no better explanation". Lancet Neurol (2006) 2.44
Profile of cognitive impairment in chronic heart failure. J Am Geriatr Soc (2007) 2.43
Midlife blood pressure and the risk of hippocampal atrophy: the Honolulu Asia Aging Study. Hypertension (2004) 2.43
Brain imaging in patients with diabetes: a systematic review. Diabetes Care (2006) 2.39
Amyloid-beta(1-42), total tau, and phosphorylated tau as cerebrospinal fluid biomarkers for the diagnosis of Alzheimer disease. Clin Chem (2009) 2.32
Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance. Brain (2002) 2.30
Prediction of conversion from mild cognitive impairment to Alzheimer's disease dementia based upon biomarkers and neuropsychological test performance. Neurobiol Aging (2010) 2.27
Tools of the trade: psychophysiological interactions and functional connectivity. Soc Cogn Affect Neurosci (2012) 2.22
Frontotemporal dementia in The Netherlands: patient characteristics and prevalence estimates from a population-based study. Brain (2003) 2.20
Magnetic resonance imaging pattern recognition in hypomyelinating disorders. Brain (2010) 2.19
N-acetylcysteine for patients with prolonged hypotension as prophylaxis for acute renal failure (NEPHRON). Crit Care Med (2007) 2.18
Early-onset versus late-onset Alzheimer's disease: the case of the missing APOE ɛ4 allele. Lancet Neurol (2010) 2.18
Ventral striatum/nucleus accumbens activation to smoking-related pictorial cues in smokers and nonsmokers: a functional magnetic resonance imaging study. Biol Psychiatry (2005) 2.17
Whole brain resting-state analysis reveals decreased functional connectivity in major depression. Front Syst Neurosci (2010) 2.16
Loss of 'small-world' networks in Alzheimer's disease: graph analysis of FMRI resting-state functional connectivity. PLoS One (2010) 2.12
Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis. Lancet Neurol (2005) 2.10
Oxidation of methane by a biological dicopper centre. Nature (2010) 2.09
MRI in multiple sclerosis: current status and future prospects. Lancet Neurol (2008) 2.08
Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology. AJNR Am J Neuroradiol (2005) 2.07
Grey matter volume in a large cohort of MS patients: relation to MRI parameters and disability. Mult Scler (2011) 2.07
Lack of association between antimyelin antibodies and progression to multiple sclerosis. N Engl J Med (2007) 2.06
Functional connectomics from resting-state fMRI. Trends Cogn Sci (2013) 2.05
Constrained linear basis sets for HRF modelling using Variational Bayes. Neuroimage (2004) 2.03
Medial temporal lobe atrophy on MRI predicts dementia in patients with mild cognitive impairment. Neurology (2004) 2.00
An alternate conformation and a third metal in PstP/Ppp, the M. tuberculosis PP2C-Family Ser/Thr protein phosphatase. Structure (2004) 1.99
Fully Bayesian spatio-temporal modeling of FMRI data. IEEE Trans Med Imaging (2004) 1.98
Designing drug trials for Alzheimer's disease: what we have learned from the release of the phase III antibody trials: a report from the EU/US/CTAD Task Force. Alzheimers Dement (2013) 1.98